Investigating the biochemical and oncogenic properties of the Ras GTPase RIT1

研究 Ras GTPase RIT1 的生化和致癌特性

基本信息

项目摘要

Project Summary/Abstract RIT1 is a member of the Ras family of GTPases that direct broad cellular physiological responses through tightly controlled signaling networks. RIT1 has been recently described as an oncogenic driver of lung adenocarcinoma and myeloid malignancies. Despite the emerging role of RIT1 mutations in cancer, RIT1 remains a poorly studied member of the Ras GTPase family. To identify and characterize properties of RIT1 that may contribute to the pathogenesis of RIT1 disease, we performed a mass spectrometry-based screen that identified a direct link with components of the spindle assembly checkpoint (SAC), a critical pathway necessary for proper chromosome segregation during mitosis. Characterization of this novel interaction has revealed that mutant RIT1 promotes aneuploidy by suppressing the SAC. Despite our preliminary evaluation, further analyses are required to understand the physiological function of this interaction and the contribution of SAC dysregulation to RIT1 oncogenicity. The objective of this proposal is to evaluate the biochemical and oncogenic properties of RIT1 associated with SAC suppression. The specific aims are to 1) interrogate the physiological function and regulation of the RIT1-SAC interaction and 2) examine the molecular determinants of RIT1-mediated oncogenicity. Aim 1 will be achieved using biochemical, structural, and cell biological approaches to assess the regulation of the RIT1-SAC interaction, its structural characteristics, and its functional consequences using primary gain-of-function and loss-of-function cell models. Aim 2 will focus on a set of ongoing RIT1 mouse model studies to a) assess the contribution of the RIT1-SAC interaction to RIT1 oncogenicity and b) identify secondary genetic lesions that contribute to the development of RIT1-driven tumors. The proposed research will help elucidate the mechanism of RIT1-mediated tumorigenesis in order to identify potential vulnerabilities that can be explored for the development of therapeutic strategies. The research strategy described in this proposal will be conducted in the lab of Dr. Frank McCormick at the UCSF Helen Diller Family Comprehensive Cancer Center. The fellowship training plan incorporates professional and career development activities aimed at 1) building upon my technical skillset in biochemistry and cancer biology, 2) improving my communication skills, 3) developing effective teaching and mentoring skills, and 4) preparing me for a postdoctoral training position. Completion of these goals would provide the experience and expertise necessary to embark on an independent research career to continue investigating the molecular mechanisms underlying the dysregulation of signal transduction pathways that contribute to cancer development and disease progression.
项目总结/文摘

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.
  • DOI:
    10.1126/sciadv.adf4766
  • 发表时间:
    2023-07-14
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Cuevas-Navarro, Antonio;Wagner, Morgan;Van, Richard;Swain, Monalisa;Mo, Stephanie;Columbus, John;Allison, Madeline R.;Cheng, Alice;Messing, Simon;Turbyville, Thomas J.;Simanshu, Dhirendra K.;Sale, Matthew J.;McCormick, Frank;Stephen, Andrew G.;Castel, Pau
  • 通讯作者:
    Castel, Pau
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Antonio Cuevas Navarro其他文献

Antonio Cuevas Navarro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 3.77万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 3.77万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 3.77万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 3.77万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了